Ignite Creation Date:
2024-05-06 @ 10:09 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03170895
Status:
COMPLETED
Last Update Posted:
2020-03-30
First Post:
2017-05-26
Brief Title:
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or RelapsedRefractory AML Carrying FLT3-ITD
Sponsor:
The University of Hong Kong
Organization:
The University of Hong Kong
Organization Data
Organization:
The University of Hong Kong
Class:
OTHER
Study ID:
AML008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Hong Kong
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Anskar YH Leung
Responsible Party Title:
Clinical Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The University of Hong Kong
Old Name:
None
Old Organization:
None